Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Announces Capacity Expansions Across Subsidiaries

Senores Pharmaceuticals announced planned capacity expansions across its subsidiaries totaling INR 43.00 Cr, targeted for completion by end of Mar'27

Senores Pharmaceuticals Announces Capacity Expansions Across Subsidiaries

Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 7:31 pm

Senores Pharmaceuticals Announces Capacity Expansions Across Subsidiaries Senores Pharmaceuticals announced planned capacity expansions across its subsidiaries totaling INR 43.00 Cr, targeted for completion by end of Mar'27. Havix Group INC (USA) will expand capacity from 1.2 Bn to 2.0 Bn units for INR 18.00 Cr, while Apnar Pharma (India) will scale from 0.5 Bn to 1.2 Bn units for INR 20.00 Cr. Additionally, Ratnatris Pharmaceuticals is adding a 2.7 Mn-unit Prefilled Syringe line for INR 5.00 Cr. Funding will be sourced via internal accruals and IPO proceeds to meet growing demand.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements